5 Ways Integrated Drug Development Solutions Save Time And Money

The cost of bringing a new drug to market has risen dramatically, from $800 million in 2004 to $2.6 billion today, with timelines remaining long due to increasing complexity in drug development. New technologies and evolving methodologies, such as adaptive trial designs and biomarker integration, have introduced both challenges and opportunities for sponsors and CROs.

Altasciences offers an integrated drug development solution to streamline and accelerate the process by reducing handoffs, leveraging adaptive trial designs, synchronizing clinical sites and bioanalytical capabilities, and providing real-time data for faster decision-making. This approach can cut research timelines by up to 40%, helping sponsors efficiently navigate early-phase drug development.